Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
292 , F1802F1809 (2007)
La L-Carnitina suplementaria es tpicamente producida mediante sntesis o fermentacin bacteriana y no proviene de fuentes animales, hacindola apropiada para dietas veganas, aunque siempre se debe verificar la composicin de la cpsula que la contiene
A patient should not stack peptides simply because multiple names sound beneficial
Potential side effects are mood swings, headaches, injection-site reactions, third spacing, and hormonal imbalances
berghei blood stages using bioluminescent reporter parasites